7-day free trial: Get unlimited comparisons, and stock, ETF and mutual fund analyses for just $15/month, without ads. Start a trial. Go ad free!
BBH vs IBB
Both BBH and IBB are ETFs. BBH has a lower 5-year return than IBB (9.1% vs 9.69%). BBH has a lower expense ratio than IBB (0.35% vs 0.46%). Below is the comparison between BBH and IBB.
| BBH | IBB | |
|---|---|---|
| Segment | Equity: Global Biotech | Equity: U.S. Biotech |
| Issuer | VanEck | BlackRock |
| Net Assets | $478.8M | $10.37B |
| Expense Ratio | 0.35% | 0.46% |
| Management Style | passive (index-based) | passive (index-based) |
| Dividend Yield | 0.36% | 0.21% |
| Underlying Index | MVIS US Listed Biotech 25 Index | NASDAQ Biotechnology Index |
| YTD Return | 3.49% | 4.45% |
| 1-Year Return | 25.76% | 31.94% |
| 3-Year Return | 11.90% | 13.68% |
| 5-Year Return | 9.10% | 9.69% |
| 10-Year Return | N/A | 17.66% |
BBH description
The Fund seeks to replicate the price and yield performance of the Market Vectors US Listed Biotech 25 Index. The Index is comprised of common stocks and depository receipts of US exchange-listed companies in biotechnology sector.
BBH performance & returns
| YTD Return | 3.49% |
| 1-Month Return | 1.50% |
| 3-Month Return | 6.05% |
| 1-Year Return | 25.76% |
| 3-Year Return | 11.90% |
| 5-Year Return | 9.10% |
| 10-Year Return | N/A |
BBH expense ratio is 0.35%.
BBH holdings
Top 10 Holdings (61.45% of Total Assets)
| Name | Symbol | % Assets |
|---|---|---|
| Amgen Inc | AMGN | 14.27% |
| Gilead Sciences Inc | GILD | 7.23% |
| Moderna Inc | MRNA | 5.48% |
| Regeneron Pharmaceuticals Inc | REGN | 5.47% |
| Exact Sciences Corp | EXAS | 5.28% |
| Alexion Pharmaceuticals Inc | ALXN | 4.92% |
| IQVIA Holdings Inc | IQV | 4.91% |
| Biogen Inc | BIIB | 4.75% |
| Vertex Pharmaceuticals Inc | VRTX | 4.59% |
| Illumina Inc | ILMN | 4.55% |
Other relevant BBH comparisons
You may also want to check out the following BBH comparisons that investors often look for on Finny
Or use Finny Compare Wizard to create a comparison you’d like to see.
IBB description
The Fund seeks to track the investment results of the NASDAQ Biotechnology Index composed of biotechnology and pharmaceutical equities listed on the NASDAQ Stock Market. The Fund invests at least 90% of its assets in securities of the Underlying Index and in depositary receipts representing securities of the Index.
IBB performance & returns
| YTD Return | 4.45% |
| 1-Month Return | 5.23% |
| 3-Month Return | 11.97% |
| 1-Year Return | 31.94% |
| 3-Year Return | 13.68% |
| 5-Year Return | 9.69% |
| 10-Year Return | 17.66% |
IBB expense ratio is 0.46%.
IBB holdings
Top 10 Holdings (46.86% of Total Assets)
| Name | Symbol | % Assets |
|---|---|---|
| Gilead Sciences Inc | GILD | 7.48% |
| Amgen Inc | AMGN | 7.35% |
| Regeneron Pharmaceuticals Inc | REGN | 6.30% |
| Vertex Pharmaceuticals Inc | VRTX | 6.02% |
| Illumina Inc | ILMN | 4.74% |
| Biogen Inc | BIIB | 3.76% |
| Seagen Inc Ordinary Shares | SGEN | 3.26% |
| Moderna Inc | MRNA | 2.99% |
| Alexion Pharmaceuticals Inc | ALXN | 2.83% |
| Incyte Corp | INCY | 2.13% |
Other relevant IBB comparisons
You may also want to check out the following IBB comparisons that investors often look for on Finny
- IBB vs JETS
- IBB vs ARKK
- IBB vs ARKG
- IBB vs IDNA
- IBB vs IHI
- IBB vs QQQ
- IBB vs VHT
- IBB vs XBI
- IBB vs XBI
Or use Finny Compare Wizard to create a comparison you’d like to see.
You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.
